Aparna Narvekar

Journal of clinical and diagnostic research : JCDR · 2015

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Aparna Narvekar trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Kay (in Molecular Biology)

Papers from Aparna Narvekar's perspective

Ordered by how strongly the researchers Aparna Narvekar trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Towards safe, non-viral therapeutic gene expression in humans (Nature reviews genetics)
  2. State-of-the-art gene-based therapies: the road ahead (Nature reviews genetics)
  3. Gene therapy: trials and tribulations (Nature reviews genetics)
  4. Progress and problems with the use of viral vectors for gene therapy (Nature reviews genetics)
  5. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. (New England Journal of Medicine)
  6. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector (Nature Genetics)
  7. Genome editing with engineered zinc finger nucleases (Nature reviews genetics)
  8. The fundamental role of epigenetic events in cancer (Nature reviews genetics)
  9. Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration (Science)
  10. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. (New England Journal of Medicine)

Their papers